More than 500 biotech companies operate in the US, doing their part to make it the world’s hub for innovation. Only about 20 …
One small step for man, one giant leap for… investors looking into aerospace stocks heading to the moon? Talk of a looming recession …
Buoyed by optimism over the label expansion of Amarin’s (AMRN) flagship drug, Vascepa, the fish oil drug maker’s stock has run off to …
Buy low, and sell high. That’s old wisdom, but it’s stayed with us through the ages because it’s a sure way to grow …
Needham, the investment bank and financial management firm that underwrote Google’s IPO back in 2005, held its annual SaaS 1×1 Conference last week. …
10 is a majestic number. Used to bestow a quality of unmatched excellence, be it as a score in a gymnastics routine, or …
Amarin (AMRN) investors received a nice gift going into the weekend, after shares of the biopharma increased by almost 12% on Friday. The …
With turkey day around the corner, investors are shopping the Street for Black Friday deals. Black Friday falls on November 29 and is …
When the dentist advises you to brush your teeth, what do you do? You brush your teeth.
Are you looking for a tip on the next hot investment? Goldman Sachs has an interesting idea… Move toward US companies with high …
